A pharmacokinetic-guided phase II trial of the rebeccamycin analog NSC 655649 [becatecarin] in pediatric patients with relapsed/refractory neuroblastoma
Phase of Trial: Phase II
Latest Information Update: 24 Jun 2013
At a glance
- Drugs Becatecarin (Primary)
- Indications Neuroblastoma
- Focus Therapeutic Use
- 04 Jun 2007 Status changed from in progress to completed.
- 19 Jan 2007 Status changed from recruiting to in progress.
- 06 Sep 2005 New trial record.